Executive Leadership

President and CEO

Chris was appointed president and CEO of Versiti on Feb. 1, 2017, after a career spanning more than 20 years exclusively in healthcare. He is first and foremost a patient and blood donor advocate who is passionate about the employee experience of more than 2,000 Versiti colleagues across Illinois, Indiana, Michigan, Ohio, Texas and Wisconsin. Together with the Versiti leadership team, Chris has strengthened Versiti’s culture and stoked the flame of blood health innovation.

EVP and Chief Laboratory Officer

Brad joined Versiti in 2001 and spent 15 years in Versiti Diagnostic Laboratories, where he developed formal processes for evaluating, approving and prioritizing innovative technologies and clinical assays into Diagnostic Labs, and led the early integration of clinical lab assets across Versiti’s footprint into a single operation. Throughout his career, he has developed broad executive leadership skills while ensuring robust governance mechanisms for both near-term performance and long-term strategic planning and execution, ultimately advancing our mission to drive blood health innovation.

Chief Medical Officer and EVP, Medical Sciences Institute

Dr. Anderson provides clinical, strategic and regulatory oversight for Versiti, including collaborations with academic and industry partners, to improve patient care through advances in laboratory medicine and clinical trials. Prior to joining Versiti, Dr. Anderson served as an assistant professor in the Department of Pathology at Stanford University School of Medicine, and as the assistant director of the Stanford Histocompatibility, Immunogenetics, and Disease Profiling Laboratory. Dr. Anderson is a graduate of the Medical Scientist Training Program at the Medical College of Wisconsin. He is board-certified in anatomic pathology, molecular genetic pathology and histocompatibility. His research interests include the use of next-generation sequencing technologies for clinical diagnostics and biomarker discovery.

Chief Marketing Officer

Gretchen brings a career-long passion for brand excellence, marketing/PR and change leadership to Versiti Clinical Trials. She has spent more than 25 years leading people and strategies within nonprofit, corporate and higher education settings and understands what makes organizations and their brands tick, thrive and transform. Gretchen earned an EdD from the University of Southern California, an MA in public relations from Webster University, and a BS Ed from Concordia University Nebraska.

Chief of Staff

Christine comes to Versiti with a wealth of experience in healthcare, leadership and strategy in both large-scale organizations as well as start-ups, including Elephas Biosciences, Exact Sciences and Merck & Co. With more than 20 years in senior commercial leadership roles in the biopharmaceutical and biotech industries, Christine has a proven track record of driving strategic initiatives and organizational transformation, all aimed at enhancing patient care and advancing healthcare standards. Christine earned a Bachelor of Science in Biological Sciences with a minor in Chemistry from the University of Wisconsin-Milwaukee. She enjoys spending time and traveling with her family, cheering on her kids, and attending theater and musical performances.

Chief Operating Officer

Brandon has 25 years of experience in regulated and research environments. He earned an undergraduate degree in biochemistry at the University of Texas. Brandon has extensive laboratory management, regulatory and project management experience, in both point-of-care and phase I-IV clinical research capacities. Additionally, he has been trained as an emergency medical technician and is a certified Lean Six Sigma Green Belt.

Founder, Pearl Pathways

Gretchen oversees the management team responsible for regulatory and quality assurance services, clinical development and Pearl IRB services, business development, finance, and business operations. Gretchen has more than 30 years of experience in the development of life-science products and the regulatory approval process. She is a recognized as a leader in the life science industry and one of only two fellows in the regulatory affairs professional society in the state of Indiana. Gretchen earned an MS in biology from Purdue University and a BS in biology from Indiana University, has been RAC certified since 2002, and is a RAPS fellow.

Chief Scientific Officer

Doug Rains has served as the chief scientific officer of Quantigen since 2015. He began his career in academia as part of the Human Genome Project at Washington University Medical School, eventually shifting into cancer research at the Health Science Center in San Antonio and, later, at Southwest Texas State University. He then spent 10 years as a qPCR and assay design specialist at Applied Biosystems (later Thermo Fisher). Before coming to Quantigen, he served as director of genetic testing for Merit Laboratory Partners in Franklin, TN. Doug currently resides just outside of Nashville, TN.

Sr. Director, Biomaterials Operations and Salus Organizational Official 

Nichole has a 16-year career with Versiti and has held multiple roles across the enterprise with increasing complexity and scope, including: research technologist, innovation and technical specialist for production and distribution, donor management supervisor, specialized production manager and director, and chief of staff. In her current role, Nichole drives excellence in Versiti’s provision of high-quality biomaterials for research and supports the operation of Salus IRB to provide ethical review services in clinical research. Nichole earned her Specialist in Blood Banking Certification in 2014, Master’s in Transfusion Medicine in 2018 and has completed Harvard Business School’s Executive Education Program for Leadership Development - a program focused on leadership, innovation and organizational change.

Vice President of Business Development

Sean joined Versiti in 2019 and has more than 20 years of experience in clinical and research diagnostics. He earned an undergraduate degree in cytotechnology at the University of Akron. Sean’s business development experience includes launching oncology diagnostics services, driving reimbursement strategies with managed care organizations, strategic partnerships, advancement of translational research platforms, and clinical trial services across all phases.